负压引流下重组人表皮生长因子结合银离子敷料治疗糖尿病足溃疡疗效

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (612 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the therapeutic effect of recombinant human epidermal growth factor combined with silver ion dressings under vacuum sealing drainage (vacuum sealing drainage, the VSD) against diabetic foot ulcer wound. Methods A total of 129 patients with diabetic foot infection treated between September 2016 and February 2019 were selected and randomly divided into three groups, with 43 cases in each. Patients in group A were treated with silver ion dressings alone, group B was additionally given recombinant human epidermal growth factor (rhEGF), while group C received vacuum sealing drainage plus the two treatments mentioned above. Wound healing was compared between the three groups after 28 days of treatment. Results The effective rate was respectively 88.4% (38/43) in group A, 93% (40/43) in group B, and 97.7% (42/43) in group C, so the difference was statistically significant (P<0.05).The VAS of group C was significantly lower than that of group B and group A, with statistically significant difference (P<0.05).In terms of wound repair, times the dressing was changed and usage of antibiotics, group C was superior to group A and group B. Conclusions The combination of recombinant human epidermal growth factor (rhEGF) with silver ions dressing under vacuum sealing drainage (VSD), when used in the treatment of diabetic foot ulcer, can effectively promote healing and granulation, so it is worthy of clinical application.

Key words： human recombinant epidermal growth factor silver ion dressing diabetic foot vacuum seal drainage ulcer

Received: 23 January 2020

ZTFLH:

R587.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Bin
	XIE Fei
	ZOU Xiaofang
	BI Fangfang
	WU Shijian
	XIAO Mengjing

Cite this article:

LI Bin,XIE Fei,ZOU Xiaofang等. Recombinant human epidermal growth factor combined with silver ions dressing in the treatment of diabetic foot ulcer under VSD[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2020, 31(5): 394-396.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2020/V31/I5/394

[1]	Zhang P, Lu J, Jing Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis[J]. Ann Med, 2016, 49(2):1-21.
[2]	Ingelfinger J R, Armstrong D G, Boulton A M, et al. Diabetic Foot Ulcers and Their Recurrence[J]. N Eng J Med, 2017, 376(24):2367-2375.
[3]	姚建华. 封闭负压引流技术治疗糖尿病足的效果观察[J]. 中国综合临床, 2017, 33(1):30-33.
[4]	国际血管联盟中国分会糖尿病足专业委员会. 糖尿病足诊治指南[J]. 介入放射学杂志,2013,22(9):705-708.
[5]	Zhang H,Li Q.Improved vacuum sealing drainage for treatment of surgical site infection following posterior spinal internal fi xation: A case report[J].Medicine,2018,97(7):9952.
[6]	杨岚清,周忠志. 负压封闭引流技术与慢性创面的研究进展[J]. 中外医学研究, 2018,16(2):180-182.
[7]	李永忠, 雷云, 陈莉, 等. 烧伤创疡再生医疗技术与负压封闭引流技术序惯应用在慢性难愈合创面治疗中的效果分析[J]. 中国烧伤创疡杂志, 2019, 31(3):153-156.
[8]	王澍, 葛斌, 唐乾利, 等. MEBT/MEBO对慢性难愈合创面组织中EGFR表达的影响[J]. 中国烧伤创疡杂志, 2018,30(1):1-11.
[9]	Shin J U,Kang S W,Jeong J J,et al.Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients[J].J Dermatolog Treat,2015,26(2):159-164.
[10]	Borys S, Hohendorff J, Koblik T, et al. Negative-pressure wound therapy for management of chronic neuropathic noninfected diabetic foot ulcerations-short-term efficacy and long-term outcomes[J]. Endocrine, 2018,62(3):611-616.
[11]	黎鸿章, 肖昌明, 银西洋, 等. 负压封闭引流治疗深度烧伤创面及对炎性因子、致痛因子的影响[J]. 创伤外科杂志, 2019, 21(1):66-70.
[12]	刘海佳,章小庆.负压技术联合湿性敷料在慢性糖尿病足患者护理中的应用效果[J].医疗装备,2018,31(17):190-191
[13]	徐丽红. VSD技术联用表皮生长因子对深度烧伤创面愈合及炎症应激反应的影响[J]. 中国美容医学, 2017,26(9):19-21.